Placental bed disorders in the genesis of the great obstetrical syndromes

Placental Bed Disorders: Basic Science and its Translation to Obstetrics

Volumn , Issue , 2010, Pages 271-289

  Romero, Roberto ^a   Kusanovic, Juan Pedro ^b   Kim, Chong Jai ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952317287     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511750847.025     Document Type: Chapter

References (188)

1. Dixon H G, Robertson WB. A study of the vessels of the placental bed in normotensive and hypertensive women. J Obstet Gynaecol Br Emp 1958; 65: 803-09.
2. Brosens I. A Study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynaecol Br Commonw 1964; 71: 222-30.
3. Browne J C, Veall N. The maternal placental blood flow in normotensive and hypertensive women. J Obstet Gynaecol BrEmp 1953; 60: 141-7.
4. Meschia G. Techniques for the study of the uteroplacental circulation. In: Rosenfeld C R, ed. The uterine circulation. Ithaca, NY: Perinatology Press; 1989: pp. 35-51.
5. Clavero-Nunez J A. Uteroplacental blood flow in pregnant women: its measurement by radioisotope techniques. In: Moawad A H, Lindheimer M D, eds. Uterine and placental blood flow. New York: Masson Publishing USA, Inc.; 1982: pp. 53-9.
6. Brosens I, Robertson W B, Dixon H G. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967; 93: 569-79.
7. Brosens I A, Robertson W B, Dixon H G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177-91.
8. Brosens I A. The uteroplacental vessels at term - the distribution and extent of physiological changes. Trophoblast Res 1988; 3: 61-7.
9. Khong T Y, De Wolf F, Robertson W B, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-59.
10. Khong T Y, Liddell H S, Robertson W B. Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol 1987; 94: 649-55.
11. Michel M Z, Khong T Y, Clark D A, Beard R W. A morphological and immunological study of human placental bed biopsies in miscarriage. Br J Obstet Gynaecol 1990; 97: 984-88.
12. Dommisse J, Tiltman A J. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992; 99: 651-54.
13. Stone S, Pijnenborg R, Vercruysse L et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006; 27: 457-67.
14. Kim Y M, Bujold E, Chaiworapongsa T et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003; 189: 1063-69.
15. Kim Y M, Chaiworapongsa T, Gomez R et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 1137-42.
16. Romero R. Prenatal medicine: the child is the father of the man. J Mat Fet Neonat Med, in press.
17. Hustin J, Jauniaux E, Schaaps J P. Histological study of the materno-embryonic interface in spontaneous abortion. Placenta 1990; 11: 477-86.
18. Gun B D, Numanoglu G, Ozdamar S O. The comparison of vessels in elective and spontaneous abortion decidua in first trimester pregnancies: importance of vascular changes in early pregnancy losses. Acta Obstet Gynecol Scand 2006; 85: 402-6.
19. Ball E, Robson S C, Ayis S, Lyall F, Bulmer J N. Early embryonic demise: no evidence of abnormal spiral artery transformation or trophoblast invasion. J Pathol 2006; 208: 528-34.
20. Ball E, Bulmer J N, Ayis S, Lyall F, Robson S C. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 2006; 208: 535-42.
21. Goldenberg R L, Culhane J F, Iams J D, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
22. Romero R, Espinoza J, Kusanovic J P et al. The preterm parturition syndrome. BJOG 2006; 113 (Suppl 3): 17-42.
23. Naeye RL, Ross SM. Amniotic fluid infection syndrome. Clin Obstet Gynaecol 1982; 9: 593-607.
24. Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137-44.
25. Romero R, Mazor M, Wu Y K et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262-79.
26. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553-84.
27. Romero R, Sirtori M, Oyarzun E et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817-24.
28. Gibbs R S, Romero R, Hillier S L et al. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515-28.
29. Goldenberg RL, Hauth J C, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500-7.
30. Yoon B H, Romero R, Moon J B et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185: 1130-36.
31. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8: 3-13.
32. Shim S S, Romero R, Hong J S et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004; 191: 1339-45.
33. Kusanovic J P, Espinoza J, Romero R et al. Clinical significance of the presence of amniotic fluid ‘sludge’ in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol 2007; 30: 706-14.
34. Romero R, Kusanovic J P, Espinoza J et al. What is amniotic fluid ‘sludge’? Ultrasound Obstet Gynecol 2007; 30: 793-98.
35. Romero R, Schaudinn C, Kusanovic J P et al. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 2008; 198: 135.
36. Arias F, Rodriquez L, Rayne S C, Kraus F T. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168: 585-91.
37. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997; 89: 265-71.
38. Iams J D, Johnson F F, Sonek J et al. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 1995; 172: 1097-103.
39. Hassan S S, Romero R, Berry S M et al. Patients with an ultrasonographic cervical length < or = 15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000; 182: 1458-67.
40. Romero R, Espinoza J, Erez O, Hassan S. The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol 2006; 194: 1-9.
41. Phelan J P, Park Y W, Ahn M O, Rutherford S E. Polyhydramnios and perinatal outcome. J Perinatol 1990; 10: 347-50.
42. Romero R, Sepulveda W, Baumann P et al. The preterm labor syndrome: biochemical, cytologic, immunologic, pathologic, microbiologic, and clinical evidence that preterm labor is a heterogeneous disease. Am J Obstet Gynecol 1993; 168(1 part 2): 287.
43. Romero R, Mazor M, Avila C, Quintero R, Munoz H. Uterine “allergy”: a novel mechanism for preterm labor. Am J Obstet Gynecol 1991; 164(1 part 2): 375.
44. Garfield R E, Bytautiene E, Vedernikov Y P, Marshall J S, Romero R. Modulation of rat uterine contractility by mast cells and their mediators. Am J Obstet Gynecol 2000; 183: 118-25.
45. Bytautiene E, Romero R, Vedernikov Y P et al. Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol 2004; 191: 1356-61.
46. Csapo A I, Pohanka O, Kaihola H L. Progesterone deficiency and premature labour. Br Med J 1974; 1: 137-40.
47. Check J H, Lee G, Epstein R, Vetter B. Increased rate of preterm deliveries in untreated women with luteal phase deficiencies: preliminary report. Gynecol Obstet Invest 1992; 33: 183-84.
48. Mazor M, Hershkovitz R, Chaim W et al. Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios. Am J Obstet Gynecol 1994; 171: 231-36.
49. Fidel P I Jr, Romero R, Maymon E, Hertelendy F. Bacteria-induced or bacterial product-induced preterm parturition in mice and rabbits is preceded by a significant fall in serum progesterone concentrations. J Matern Fetal Med 1998; 7: 222-26.
50. Germain A M, Carvajal J, Sanchez M et al. Preterm labor: placental pathology and clinical correlation. Obstet Gynecol 1999; 94: 284-89.
51. Combs C A, Katz M A, Kitzmiller J L, Brescia R J. Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol 1993; 169:215-23.
52. Arias F. Placental insufficiency: an important cause of preterm labor and preterm premature ruptured membranes. Society of Perinatal Obstetricians (10th Annual Meeting) 1990; 158.
53. Vintzileos A M, Campbell W A, Nochimson D J, Weinbaum P J. Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae. Am J Obstet Gynecol 1987; 156: 1235-38.
54. Moretti M, Sibai B M. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988; 159: 390-96.
55. Major C, Nageotte M, Lewis D. Preterm premature rupture of membranes and placental abruption: is there an association between these pregnancy complications? Am J Obstet Gynecol 1991; 164: 381.
56. Brar H S, Medearis A L, DeVore G R, Platt L D. Maternal and fetal blood flow velocity waveforms in patients with preterm labor: prediction of successful tocolysis. Am J Obstet Gynecol 1988; 159: 947-50.
57. Brar H S, Medearis A L, De Vore G R, Platt L D. Maternal and fetal blood flow velocity waveforms in patients with preterm labor: relationship to outcome. Am J Obstet Gynecol 1989; 161: 1519-22.
58. Strigini F A, Lencioni G, De Luca G et al. Uterine artery velocimetry and spontaneous preterm delivery. Obstet Gynecol 1995; 85: 374-77.
59. Weiner CP, Sabbagha RE, Vaisrub N, Depp R. A hypothetical model suggesting suboptimal intrauterine growth in infants delivered preterm. Obstet Gynecol 1985; 65: 323-26.
60. MacGregor S N, Sabbagha RE, Tamura RK, Pielet B W, Feigenbaum S L. Differing fetal growth patterns in pregnancies complicated by preterm labor. Obstet Gynecol 1988; 72: 834-37.
61. Ott W J. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol 1993; 168: 1710-15.
62. Zeitlin J, Ancel P Y, Saurel-Cubizolles M J, Papiernik E. The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study. BJOG 2000; 107: 750-58.
63. Bukowski R, Gahn D, Denning J, Saade G. Impairment of growth in fetuses destined to deliver preterm. Am J Obstet Gynecol 2001; 185: 463-67.
64. Morken N H, Kallen K, Jacobsson B. Fetal growth and onset of delivery: a nationwide population-based study of preterm infants. Am J Obstet Gynecol 2006; 195: 154-61.
65. Espinoza J, Kusanovic J P, Kim C J et al. An episode of preterm labor is a risk factor for the birth of a small-for- gestational-age neonate. Am J Obstet Gynecol 2007; 196: 574-75.
66. Poisner A M. The human placental renin-angiotensin system. Front Neuroendocrinol 1998; 19: 232-52.
67. Katz M, Shapiro W B, Porush J G, Chou S Y, Israel V. Uterine and renal renin release after ligation of the uterine arteries in the pregnant rabbit. Am J Obstet Gynecol 1980; 136: 676-78.
68. Woods LL, Brooks VL. Role of the renin-angiotensin system in hypertension during reduced uteroplacental perfusion pressure. Am J Physiol 1989; 257: R204-R209.
69. Lalanne C, Mironneau C, Mironneau J, Savineau J P. Contractions of rat uterine smooth muscle induced by acetylcholine and angiotensin II in Ca2+-free medium. Br J Pharmacol 1984; 81: 317-26.
70. Campos G A, Guerra F A, Israel E J. Angiotensin II induced release of prostaglandins from rat uterus. Arch Biol Med Exp (Santiago) 1983; 16: 43-9.
71. Lockwood C J, Krikun G, Papp C et al. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann N Y Acad Sci 1994; 734: 57-79.
72. Elovitz M A, Saunders T, Ascher-Landsberg J, Phillippe M. Effects of thrombin on myometrial contractions in vitro and in vivo. Am J Obstet Gynecol 2000; 183: 799-804.
73. Rosen T, Schatz F, Kuczynski E et al. Thrombin- enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002; 11: 11-17.
74. Lockwood C J, Krikun G, Aigner S, Schatz F. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab 1996; 81: 107-12.
75. Lijnen H R. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mos.) 2002; 67: 92-8.
76. Aplin J D, Campbell S, Allen T D. The extracellular matrix of human amniotic epithelium: ultrastructure, composition and deposition. J Cell Sci 1985; 79: 119-36.
77. Chaiworapongsa T, Espinoza J, Yoshimatsu J et al. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11: 368-73.
78. Gomez R, Athayde N, Pacora P et al. Increased thrombin in intrauterine inflammation. Am J Obstet Gynecol 1998; 178: S62.
79. Rosen T, Kuczynski E, O’Neill LM, Funai EF, Lockwood C J. Plasma levels of thrombin- antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001; 10: 297-300.
80. Nagy S, Bush M, Stone J, Lapinski RH, Gardo S. Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Obstet Gynecol 2003; 102: 94-100.
81. Funderburk S J, Guthrie D, Meldrum D. Outcome of pregnancies complicated by early vaginal bleeding. Br J Obstet Gynaecol 1980; 87: 100-5.
82. Williams M A, Mittendorf R, Lieberman E, Monson R R. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 1991; 78: 14-18.
83. Signore C C, Sood A K, Richards D S. Second-trimester vaginal bleeding: correlation of ultrasonographic findings with perinatal outcome. Am J Obstet Gynecol 1998; 178: 336-40.
84. Gomez R, Romero R, Nien J K et al. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005; 18: 31-7.
85. Ananth C V, Wilcox A J. Placental abruption and perinatal mortality in the United States. Am J Epidemiol 2001; 153: 332-37.
86. Mooney E E, al Shunnar A, O’Regan M, Gillan J E. Chorionic villous haemorrhage is associated with retroplacental haemorrhage. Br J Obstet Gynaecol 1994; 101: 965-69.
87. Branch D W, Dudley D J, Scott J R, Silver R M. Antiphospholipid antibodies and fetal loss. N Engl J Med 1992; 326: 952-54.
88. Stone S, Hunt B J, Seed P T et al. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol 2003; 188: 454-60.
89. Abramowsky C R, Vegas M E, Swinehart G, Gyves M T. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980; 303: 668-72.
90. De Wolf F, Carreras L O, Moerman P et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829-34.
91. Out H J, Kooijman CD, Bruinse H W, Derksen RH. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41: 179-86.
92. Girardi G, Berman J, Redecha P et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644-54.
93. Girardi G, Redecha P, Salmon J E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10: 1222-26.
94. Sebire N J, Fox H, Backos M et al. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002; 17: 1067-71.
95. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-42.
96. Robinson J S, Kingston E J, Jones C T, Thorburn G D. Studies on experimental growth retardation in sheep: the effect of removal of endometrial caruncles on fetal size and metabolism. J Dev Physiol 1979; 1: 379-98.
97. Robinson J S, Hart I C, Kingston E J, Jones C T, Thorburn G D. Studies on the growth of the fetal sheep. The effects of reduction of placental size on hormone concentration in fetal plasma. J Dev Physiol 1980; 2: 239-48.
98. Falconer J, Owens J A, Allotta E, Robinson J S. Effect of restriction of placental growth on the concentrations of insulin, glucose and placental lactogen in the plasma of sheep. J Endocrinol 1985; 106: 7-11.
99. Lockwood C J, Wein R, Lapinski R et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol 1993; 169: 798-804.
100. Iams J D, Goldenberg R L, Meis P J et al. The length of the cervix and the risk of spontaneous premature delivery: National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Eng J Med 1996; 334: 567-72.
101. Goldenberg RL, Mercer B M, Iams J D et al. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1997; 177: 8-12.
102. Taipale P, Hiilesmaa V. Sonographic measurement of uterine cervix at 18-22 weeks’ gestation and the risk of preterm delivery. Obstet Gynecol 1998; 92: 902-07.
103. Andrews W W, Copper R, Hauth J C et al. Second- trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol 2000; 95: 222-26.
104. Goldenberg R L, Iams J D, Das A et al. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000; 182: 636-43.
105. Heath V C, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides K H. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG 2000; 107: 1276-81.
106. To M S, Skentou C, Liao A W, Cacho A, Nicolaides K H. Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol 2001; 18: 200-3.
107. Shennan A, Jones G, Hawken J et al. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety. BJOG 2005; 112: 293-98.
108. Hassan S, Romero R, Hendler I et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006; 34: 13-19.
109. Cassell GH, Davis R O, Waites KB et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10: 294-302.
110. Gray D J, Robinson H B, Malone J, Thomson R B Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992; 12: 111-17.
111. Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995; 40: 375-79.
112. Gerber S, Vial Y, Hohlfeld P, Witkin S S. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003; 187: 518-21.
113. Nguyen D P, Gerber S, Hohlfeld P, Sandrine G, Witkin S S. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004; 32: 323-26.
114. Carroll SG, Papaioannou S, Ntumazah IL, Philpott- Howard J, Nicolaides K H. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1996; 103: 54-9.
115. Stepan H, Faber R. Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol 2007; 109: 1205-6.
116. Espinoza J, Romero R, Nien J K et al. A role of the antiangiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med 2006; 19: 607-13.
117. Rana S, Venkatesha S, DePaepe M et al. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol 2007; 109: 549-52.
118. Gant N F, Daley G L, Chand S, Whalley P J, MacDonald P C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682-89.
119. Gant N F, Chand S, Whalley P J, MacDonald P C. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974; 43: 854.
120. Harrington K F, Campbell S, Bewley S, Bower S. Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol 1991; 42 (Suppl): S14-S20.
121. Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993; 82: 78-83.
122. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996; 7: 182-88.
123. Irion O, Masse J, Forest J C, Moutquin J M. Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women. Br J Obstet Gynaecol 1998; 105: 422-29.
124. Aardema M W, De Wolf B T, Saro M C et al. Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries. Ultrasound Obstet Gynecol 2000; 16: 630-34.
125. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides K H. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol 2000; 96: 559-64.
126. Chien P F, Arnott N, Gordon A, Owen P, Khan K S. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 2000; 107: 196-208.
127. Lees C, Parra M, Missfelder-Lobos H et al. Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks. Obstet Gynecol 2001; 98: 369-73.
128. Papageorghiou A T, Yu C K, Bindra R, Pandis G, Nicolaides K H. Multicenter screening for preeclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 441-49.
129. Papageorghiou A T, Yu C K, Cicero S, Bower S, Nicolaides K H. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002; 12: 78-88.
130. Yu CK, Papageorghiou AT, Boli A, Cacho AM, Nicolaides K H. Screening for pre-eclampsia and fetal growth restriction in twin pregnancies at 23 weeks of gestation by transvaginal uterine artery Doppler. Ultrasound Obstet Gynecol 2002; 20: 535-40.
131. Papageorghiou A T, Yu C K, Erasmus I E, Cuckle H S, Nicolaides K H. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005; 112: 703-9.
132. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides K H. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005; 193: 429-36.
133. Espinoza J, Romero R, Nien J K et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-326.e13.
134. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides K H. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of preeclampsia. Ultrasound Obstet Gynecol 2008; 32:138-46.
135. Livingston J C, Haddad B, Gorski L A et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 184: 1218-20.
136. Su Y N, Lee C N, Cheng WF et al. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001; 97: 898-904.
137. Tidwell S C, Ho H N, Chiu W H, Torry R J, Torry D S. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267-72.
138. Tjoa M L, van Vugt J M, Mulders M A et al. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001; 98: 600-7.
139. Chappell L C, Seed P T, Briley A et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127-36.
140. Taylor RN, Grimwood J, Taylor R S et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177-82.
141. Krauss T, Pauer H U, Augustin H G. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004; 23: 101-11.
142. Levine R J, Maynard S E, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
143. Thadhani R, Mutter W P, Wolf M et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770-75.
144. Chaiworapongsa T, Romero R, Kim Y M et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3-18.
145. Parra M, Rodrigo R, Barja P et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193: 1486-91.
146. Levine R J, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
147. Moore Simas T A, Crawford S L, Solitro M J et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007; 197: 244-48.
148. Ohkuchi A, Hirashima C, Matsubara S et al. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151-59.
149. Robinson C J, Johnson D D. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol 2007; 197: 174-75.
150. Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49: 818-24.
151. Unal E R, Robinson C J, Johnson D D, Chang E Y. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am J Obstet Gynecol 2007; 197:211-14.
152. Akolekar R, Zaragoza E, Poon L C, Pepes S, Nicolaides K H. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of preeclampsia. Ultrasound Obstet Gynecol 2008; 32: 732-39.
153. Baumann M U, Bersinger N A, Mohaupt M G et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008; 199: 266.
154. Crispi F, Llurba E, Dominguez C et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 303-9.
155. Erez O, Romero R, Espinoza J et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008; 21: 279-87.
156. Lim J H, Kim S Y, Park S Y et al. Effective prediction of preeclampsia by a combined ratio of angiogenesis- related factors. Obstet Gynecol 2008; 111: 1403-9.
157. Stepan H, Geipel A, Schwarz F et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008; 198: 175-76.
158. Nicolaides K H, Bindra R, Turan O M et al. A novel approach to first-trimester screening for early preeclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006; 27:13-17.
159. Chafetz I, Kuhnreich I, Sammar M et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007; 197: 35-7.
160. Gonen R, Shahar R, Grimpel YI et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG 2008; 115: 1465-72.
161. Romero R, Kusanovic J P, Than N G et al. First- trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008; 199: 122.
162. Khalil A, Cowans N J, Spencer K et al. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn, in press.
163. McCowan LM, North RA, Harding JE. Abnormal uterine artery Doppler in small-for-gestational-age pregnancies is associated with later hypertension. Aust N Z J Obstet Gynaecol 2001; 41: 56-60.
164. Page EW. On the pathogenesis of pre-eclampsia and eclampsia. J Obstet Gynaecol Br Commonw 1972; 79: 883-94.
165. Adams EM, Finlayson A. Familial aspects of preeclampsia and hypertension in pregnancy. Lancet 1961; 2: 1375-78.
166. Chesley L C, Annitto J E, Cosgrove R A. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968; 32: 303-11.
167. Cooper D W, Liston W A. Genetic control of severe pre-eclampsia. J Med Genet 1979; 16: 409-16.
168. Sutherland A, Cooper D W, Howie P W, Liston W A, MacGillivray I. The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls. BJOG 1981; 88: 785-91.
169. Arngrimsson R, Bjornsson S, Geirsson RT et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. BJOG 1990; 97: 762-69.
170. Alexander B T. Prenatal influences and endothelial dysfunction: a link between reduced placental perfusion and preeclampsia. Hypertension 2007; 49: 775-76.
171. Harrison G A, Humphrey K E, Jones N et al. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am JHum Genet 1997; 60: 1158-67.
172. Arngrimsson R, Sigurard T S, Frigge ML et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999; 8: 1799-805.
173. Moses E K, Lade J A, Guo G et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for preeclampsia, on chromosome 2. Am J Hum Genet 2000; 67: 1581-85.
174. Lachmeijer A M, Arngrimsson R, Bastiaans E J et al. A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet. 2001; 9: 758-64.
175. Laivuori H, Lahermo P, Ollikainen V et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003; 72: 168-77.
176. Kalmyrzaev B, Aldashev A, Khalmatov M et al. Genome-wide scan for premature hypertension supports linkage to chromosome 2 in a large Kyrgyz family. Hypertension 2006; 48: 908-13.
177. Moses EK, Fitzpatrick E, Freed K A et al. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod 2006; 12: 505-12.
178. Johnson M P, Fitzpatrick E, Dyer T D et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod 2007; 13: 61-67.
179. Goddard K A, Tromp G, Romero R et al. Candidate- gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered 2007; 63: 1-16.
180. Parimi N, Tromp G, Kuivaniemi H et al. Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia. BMC Med Genet 2008; 9: 60.
181. Stone J L, Lockwood C J, Berkowitz G S et al. Risk factors for severe preeclampsia. Obstet Gynecol 1994; 83: 357-61.
182. Sibai B M, Gordon T, Thom E et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172: 642-48.
183. O’Brien T E, Ray J G, Chan W S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14: 368-74.
184. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15: 475-82.
185. Bodnar L M, Catov J M, Klebanoff M A, Ness R B, Roberts J M. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007; 18: 234-39.
186. Faas M M, Schuiling G A, Baller J F, Visscher C A, Bakker W W. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171: 158-64.
187. Faas MM, Schuiling GA, Linton EA, Sargent IL, Redman C W. Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol 2000; 182: 351-57.
188. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198: 7-22.